SEB Asset Management’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
SEB Asset Management's MDLN Position: Q3 2026 in Review
SEB Asset Management reduced its Medline (MDLN) stake by 38% in Q3 2026, selling an estimated $2.26M and leaving 100,643 shares worth $3.49M. The position accounts for 0.01% of the portfolio, ranked #505.
SEB Asset Management first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $6.41M in Q2 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.
- SEB Asset Management held 100,643 shares of Medline worth $3.49M as of Q3 2026.
- SEB Asset Management sold 61,790 Medline shares in Q3 2026, an estimated $2.26M.
- Medline made up 0.01% of SEB Asset Management's portfolio in Q3 2026, its #505 holding.
- SEB Asset Management first reported a position in Medline in Q2 2026 and has held it in 2 quarters since.
- SEB Asset Management's Medline position peaked at $6.41M in Q2 2026.
- 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.